Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL

NCT03460522 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
65
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nicola Goekbuget